Millennium Management’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
+170,322
| New | +$1.14M | ﹤0.01% | 2952 |
|
|
2025
Q1 | – | Sell |
-12,527
| Closed | -$217K | – | 4416 |
|
|
2024
Q4 | $217K | Sell |
12,527
-98,416
| -89% | -$1.7M | ﹤0.01% | 3643 |
|
|
2024
Q3 | $1.77M | Sell |
110,943
-36,363
| -25% | -$581K | ﹤0.01% | 2624 |
|
|
2024
Q2 | $2.1M | Buy |
147,306
+75,360
| +105% | +$1.07M | ﹤0.01% | 2462 |
|
|
2024
Q1 | $1.02M | Buy |
71,946
+47,979
| +200% | +$680K | ﹤0.01% | 2945 |
|
|
2023
Q4 | $362K | Buy |
+23,967
| New | +$362K | ﹤0.01% | 3321 |
|
|
2023
Q3 | – | Sell |
-18,298
| Closed | -$277K | – | 4590 |
|
|
2023
Q2 | $277K | Sell |
18,298
-178,955
| -91% | -$2.71M | ﹤0.01% | 3572 |
|
|
2023
Q1 | $2.86M | Buy |
197,253
+157,359
| +394% | +$2.28M | ﹤0.01% | 2286 |
|
|
2022
Q4 | $539K | Buy |
+39,894
| New | +$539K | ﹤0.01% | 3583 |
|
|
2022
Q3 | – | Sell |
-76,498
| Closed | -$932K | – | 5544 |
|
|
2022
Q2 | $932K | Buy |
+76,498
| New | +$932K | ﹤0.01% | 3469 |
|
|
2022
Q1 | – | Sell |
-46,504
| Closed | -$796K | – | 5649 |
|
|
2021
Q4 | $796K | Buy |
+46,504
| New | +$796K | ﹤0.01% | 3663 |
|